Andrea Gabrio
Andrea Gabrio
Home
Blog
Research
Publications
Talks
Software
Tutorials
Missing Data
N Clarke
Latest
Addition of abiraterone to first-line long-term hormone therapy in prostate cancer (STAMPEDE): Model to estimate long-term survival, quality-adjusted survival, and cost-effectiveness
Cite
×